Wed, Nov 04, 2026 - Page 68
24697 indexed SquawkNews stories from this UTC day. Showing 8041-8160.
M
Charles River Laboratories Reports 2026 Revenue of $982.73M, EPS of $6.86
Revenue fell 2.2% year over year, while net income rose to $333.07 million and diluted EPS increased to $6.86. Management cited improving demand, particularly in Discovery and Safety Assessment.
EARNINGS | Nov 04, 2026, 02:11 PM UTC
L
Invesco CFO Allison Dukes to Attend BMO Financial Conference
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Clopos Raises AZN 500,000 From SABAH.angels
Clopos, an IT Park Ventures portfolio company, raised AZN 500,000 from SABAH.angels.
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Invesco CFO Allison Dukes to Attend BMO Financials Conference
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
OpenTable: Some Americans Plan Higher Restaurant Spending in 2027
OpenTable says some Americans plan to spend more on restaurant visits in 2027.
EQUITY | Nov 04, 2026, 02:11 PM UTC
H
Iran's State Media Citing IRGC Says A Us Mq1 Drone Was Destroyed By Iranian Air Defences Over Qeshm Island
Iran's State Media Citing IRGC Says A Us Mq1 Drone Was Destroyed By Iranian Air Defences Over Qeshm Island
GEOPOLITICS | Nov 04, 2026, 02:11 PM UTC
L
JPMorgan Says Global Oil Market Returning to Surplus
JPMorgan said recovering Middle East exports and soft demand are pushing the global oil market back into oversupply.
ENERGY | Nov 04, 2026, 02:11 PM UTC
L
Weekly Options Listed on 2X Long DRAM ETF
Weekly options are now available on the Roundhill T-REX 2X Long DRAM ETF (RAM).
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
OpenTable Report: 76% of Americans Expect Steady or Higher Dining-Out Spending in 2027
An OpenTable report says 76% of Americans expect their dining-out spending to remain steady or increase in 2027.
EQUITY | Nov 04, 2026, 02:11 PM UTC
H
Iran's State Media citing IRGC; A US MQ1 drone was destroyed by Iranian air defenses over Qeshm Island.
Iran's State Media citing IRGC; A US MQ1 drone was destroyed by Iranian air defenses over Qeshm Island.
GEOPOLITICS | Nov 04, 2026, 02:11 PM UTC
L
OpenTable: 76% of Americans Expect Restaurant Spending to Hold or Rise in 2027
OpenTable reports that 76% of Americans expect to maintain or increase restaurant spending in 2027.
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Aggreko Introduces New Line of Battery Energy Storage Systems
ENERGY | Nov 04, 2026, 02:11 PM UTC
L
Canaccord initiates Carrier Connect coverage with Speculative Buy rating
Canaccord Genuity initiated coverage of Carrier Connect Data Solutions with a Speculative Buy rating and a C$3 price target.
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
ADC Therapeutics’ Zynlonta Combination Shows 88.7% Response Rate
The combination showed an 88.7% response rate in a Phase 1b lymphoma trial.
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Kraft Heinz CEO Calls North American Coffee Unit Divestiture a Portfolio-Simplification Step
Kraft Heinz's CEO described the divestiture as an important step in simplifying and strengthening the portfolio.
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
OpenTable: 76% de estadounidenses prevé mantener o aumentar gasto en restaurantes en 2027
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Caribou Biosciences Plans to Present CAR-T Trial Data at ASH 2026
EQUITY | Nov 04, 2026, 02:11 PM UTC
L
Amylyx to Host Investor Event on Phase 3 Avexitide Results
Amylyx Pharmaceuticals will host an investor event to discuss Phase 3 Avexitide results.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Scope says Democratic sweep supports US AA- rating, stable outlook
Scope Ratings said a Democratic sweep in the US midterm elections supports the country's AA- sovereign rating and stable outlook.
RATES | Nov 04, 2026, 02:10 PM UTC
L
Luxfer Holdings files Form 8-K
Luxfer Holdings PLC filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
RBC Raises Louisiana-Pacific Price Target to $85 From $84
RBC kept its Outperform rating on Louisiana-Pacific.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
First Berlin Research Rates Verve Group SE Buy
First Berlin Equity Research issued a buy rating on Verve Group SE.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
PetSmart Launches Merry & Bright Holiday Collection
PetSmart says its holiday collection includes seasonal treats, toys, festive looks and gifts.
EQUITY | Nov 04, 2026, 02:10 PM UTC
M
U.S. crude falls 3% to 93.25 dollars a barrel
ENERGY | Nov 04, 2026, 02:10 PM UTC
L
UBS Cuts SSR Mining Price Target to C$52 From C$55
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Aggreko Introduces Battery Energy Storage Systems for Large-Scale Use
ENERGY | Nov 04, 2026, 02:10 PM UTC
M
Nooks Secures $500M and Launches AI Sales Assistant Node
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
UBS Cuts EMCOR Group Price Target to $925 From $1,065, Keeps Buy
UBS lowered its price target on EMCOR Group to $925 from $1,065 while maintaining a Buy rating.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Marlow Shareholders Expected to Hold 9% of MPC Oceanic Group After Capital Increase
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Genmab kündigt erste Phase-3-Daten zu Epcoritamab plus Lenalidomid bei Lymphom an
EQUITY | Nov 04, 2026, 02:10 PM UTC
M
Charles River Laboratories Reports Higher Third-Quarter Income
Charles River Laboratories reported net income of $333.067 million, or $6.86 per share, compared with $54.422 million a year earlier. The supplied report is truncated.
EARNINGS | Nov 04, 2026, 02:10 PM UTC
L
Genmab Presents First Phase 3 Epcoritamab Results in Lymphoma
Genmab will present the first Phase 3 results for epcoritamab, a lymphoma treatment, at ASH.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
CoStar melhora previsão de curto prazo para mercado imobiliário de retalho nos EUA
EQUITY | Nov 04, 2026, 02:10 PM UTC
M
Castor Maritime Sets $126 Million Price for 41% Stake
The purchase price comprises $97 million in cash and $29 million in shares.
MNA | Nov 04, 2026, 02:10 PM UTC
L
Evaxion Reports New Data Supporting EVX-04 AML Vaccine
Evaxion says new data support its EVX-04 vaccine for acute myeloid leukemia. The supplied report does not specify the data or results.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Ellenbarrie Industrial Gases Reports September-Quarter Revenue of 1.14 Billion Rupees
EARNINGS | Nov 04, 2026, 02:10 PM UTC
M
BIOREM Reports Q3 Revenue of CA$16.6M
BIOREM reported Q3 revenue of CA$16.6 million, versus a FactSet estimate of CA$13.3 million.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
UBS Raises Flywire Price Target to $21.50 From $19, Keeps Neutral Rating
EQUITY | Nov 04, 2026, 02:10 PM UTC
M
CoStar Raises Near-Term US Retail Outlook
CoStar raised its near-term U.S. retail outlook as demand beat expectations.
EARNINGS | Nov 04, 2026, 02:10 PM UTC
L
Scotiabank Updates Its Financial Calendar
The Bank of Nova Scotia updated its financial calendar. The body says Scotiabank will publish something, but the text is truncated.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Slower Data Center Builds Could Crimp Natural Gas Demand Growth
An EBW Analytics note says the effect of Democratic midterm wins on U.S. natural gas is likely limited, with the Trump administration retaining control of the Department of Energy and EPA.
ENERGY | Nov 04, 2026, 02:10 PM UTC
L
Scotiabank Updates Its Financial Calendar
The Bank of Nova Scotia published an update to its financial calendar.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Healthcare Stocks Advance Premarket
Healthcare stocks were advancing premarket Wednesday.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Agilysys Sees AI Driving More Personalized Foodservice Experiences
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
J.P. Morgan Exchange-Traded Fund Files Form 497
J.P. Morgan filed a Form 497 on November 4.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Feedonomics Joins Amazon Shop Direct Merchant Workspace
Feedonomics is now available in Amazon’s Shop Direct merchant workspace.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
CDT Equity Inc. Files Form 424B3
CDT Equity Inc. filed a Form 424B3. The filing date is listed as November 4, 20.
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Tangram to Present TGM-148 Preclinical Data at ASH 2026
EQUITY | Nov 04, 2026, 02:10 PM UTC
L
Hemab Therapeutics to Present Blood Coagulation Data at ASH Meeting
Hemab plans to present clinical and preclinical data from multiple blood coagulation programs at the 68th ASH Annual Meeting and Exposition.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Helikon Fund Buys 1.05 Billion Banque du Caire Shares
Helikon Long Short Equity Fund Master ICAV bought 1.05 billion shares in Banque du Caire, according to the EGX.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Marsh Says Private-Market AUM Rises
Marsh reports that private-market assets under management increased.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Daré Bioscience to Present at Stifel Healthcare Conference
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Vox Royalty Expects More Than 10 Assets to Start or Restart Production by Mid-2029
Vox Royalty says more than 10 royalty and streaming assets could begin or resume production from Q4 2026 to H1 2029, potentially increasing its producing asset count to more than 20. The expectations are based on operato
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Lexaria Enters Agreement to Evaluate DehydraTECH Technology
Lexaria entered an agreement to evaluate its DehydraTECH technology with one or more proprietary molecules for an unnamed pharmaceutical company. The parties may pursue a licensing agreement if the evaluation is successf
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
SELLAS to Present Phase 2 SLS009 Data at ASH 2026
SELLAS said it will present Phase 2 data on SLS009 with azacitidine and venetoclax in patients with AML previously treated with venetoclax. The release cites a 54% overall response rate and median overall survival of 5.8
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Polish Zloty Stays Higher Against Euro After Rate Hold
The zloty was little changed after Poland's central bank kept interest rates at 3.75%, as expected. Capital Economics economist William Jackson said the decision was not in doubt.
FX | Nov 04, 2026, 02:09 PM UTC
L
Evaxion to Present EVX-04 Target Validation Data at ASH 2026
Evaxion says it will present new target validation data for its off-the-shelf therapeutic vaccine for acute myeloid leukemia at the ASH 2026 Meeting.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Syndax Reports 19 Abstracts Accepted for ASH 2026
Fourteen accepted abstracts concern revumenib, including seven oral presentations. The company says they address activity across acute leukemia subtypes and treatment settings.
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Marsh Completes Acquisition of AltamarCAM
MNA | Nov 04, 2026, 02:09 PM UTC
L
Marsh Reports Growth in Private-Markets Assets Under Management
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Evaxion A/S files Form 6-K
Evaxion A/S filed a Form 6-K on November 4.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Verizon Details Stadium Upgrades and Private Wireless Network for 2026 NFL Season
Verizon says it is upgrading stadiums and providing a global private wireless network for the 2026 NFL season.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Tangram to Present TGM-148 Preclinical Data at ASH 2026
Tangram says it will give an oral presentation of TGM-148 preclinical data at the American Society of Hematology 2026 Annual Meeting.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Hemab Reports Sutacimig Cut Prothrombin Time by Over 50% in Two Participants
Two participants with severe congenital Factor VII deficiency received one sutacimig dose, and both had prothrombin time shorten by more than 50%. One participant with available data showed approximately 5x accumulation
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
ShelfieTech Closes Acquisition of Majority Interest in Aspect
ShelfieTech says it closed its previously announced acquisition of a majority interest in Aspect on November 4.
MNA | Nov 04, 2026, 02:09 PM UTC
L
State and Local Pension Funds Hold at Least $578 Billion in AI Companies
AI-related companies made up 35.1% of reported public pension equity holdings as of June 30, 2026.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Lakefront Biotherapeutics Announces ASH Poster Presentation
The poster will present data from ongoing Phase 1b studies of gamgertamig in autoimmune cytopenias. The company says results suggest potential to maintain remission after B-cell reconstitution without background therapy.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Hemab to Present Coagulation Program Data at ASH Meeting
The company says initial Phase 2b data for sutacimig in Factor VII deficiency showed multi-fold accumulation of endogenous FVII(a) and shorter prothrombin time after one subcutaneous dose. Preclinical data showed HMB-003
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Vox Royalty Expects Over 10 Assets to Start or Resume Production by Mid-2029
EARNINGS | Nov 04, 2026, 02:09 PM UTC
L
Agios to Present New Clinical Data at ASH 2026
Agios announced that it will present new clinical data for mitapivat in sickle cell disease and AG-236 in polycythemia vera at ASH 2026.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
CRISPR Therapeutics to Present Zugo-Cel Data at ASH Meeting
CRISPR Therapeutics announced it will present clinical data from its ongoing Phase 1/2 zugo-cel trial in patients with relapsed or refractory large B-cell lymphoma at the 68th ASH Annual Meeting and Exposition.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Rimini Street Wins Software Support Framework Agreement With France’s CANUT
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Lyell Immunopharma Announces $80M Private Placement
Lyell Immunopharma says the private placement will advance Ronde-Cel toward a planned BLA submission.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Guided Therapeutics Enrolls Over 250 Women in Türkiye Cervical Cancer Screening Study
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Enviri Exits Deutsche Bahn Contract, Expects $19 Million Gain
Enviri released Harsco Rail from its Deutsche Bahn contract after repaying approximately $73 million in advances. The company expects a net gain of approximately $19 million with third-quarter earnings, with additional G
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Option Care Health Reports Q3 Earnings, Revenue Rise and Withdraws Guidance
Option Care Health reported higher Q3 adjusted earnings and revenue and withdrew guidance due to a pending merger.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Daré Bioscience to Present at Stifel Healthcare Conference
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
FP Movement Hosts Annual Festive 5K for Girls Inc.
FP Movement hosted its sixth annual Festive 5K benefiting Girls Inc.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Circana Launches Product Concept Testing and Forecasting Solutions
Circana says the solutions will help brands assess product ideas and predict sales potential.
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Burjeel Holdings and Burjeel Sukuk report third-quarter results
EQUITY | Nov 04, 2026, 02:09 PM UTC
M
Solstice Raises Annual Outlook on AI-Related Demand
Solstice raised its annual forecast, citing AI-related demand that drove quarterly results above expectations.
EARNINGS | Nov 04, 2026, 02:09 PM UTC
L
UBS Cuts Dynatrace Price Target to $75 From $80, Keeps Buy Rating
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Lyell Immunopharma files Form 8-K
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
KSH International Reports September-Quarter Profit of 479.5 Million Rupees
EARNINGS | Nov 04, 2026, 02:09 PM UTC
M
Solstice Raises Annual Outlook as AI Demand Drives Quarterly Results Above Expectations
Solstice raised its annual forecasts, citing AI-related demand and quarterly results above expectations.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
Charles River Laboratories files Form 10-Q
Charles River Laboratories filed a Form 10-Q. The filing is for Sep 26.
EQUITY | Nov 04, 2026, 02:09 PM UTC
L
JPMorgan Cuts AutoNation to Neutral From Overweight
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
IR-MED Reports 87.7% Interim Accuracy in Pressure-Injury Study
A peer-reviewed Phase 2 interim analysis of IR-MED’s investigational device reported 87.7% accuracy, 90.0% sensitivity and 87.3% specificity, with accuracy up 6.5 percentage points versus Phase 1. Phase 2 enrollment is o
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Turkey Parliament Set to Ratify Defence Pact With Saudi Arabia and Pakistan
Turkey's parliament is set to ratify a defence pact with Saudi Arabia and Pakistan as Houthi attacks mount.
GEOPOLITICS | Nov 04, 2026, 02:08 PM UTC
L
Ravindra Energy Unit Signs MoU for 500 Electric Commercial Vehicles
Energy In Motion signed a strategic MoU with Sorigin Green Mobility to deploy 500 electric heavy commercial vehicles.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Rate fixing STHY15
RATES | Nov 04, 2026, 02:08 PM UTC
M
Uniparts India Reports September-Quarter Consolidated Profit of 544.3 Million Rupees
EARNINGS | Nov 04, 2026, 02:08 PM UTC
L
Syndax Reports High Remission Rates in Frontline Revumenib Trials
Syndax reported high remission rates in frontline revumenib combination trials ahead of ASH 2026.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Ellenbarrie Industrial Gases Reports September-Quarter PAT of 356.5 Million Rupees
EARNINGS | Nov 04, 2026, 02:08 PM UTC
L
Analysts Split on AMD After Third-Quarter Results
Wall Street remains divided on AMD’s valuation. Mizuho lowered its price target to $610 from $705 while maintaining an Outperform rating.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Verizon Adds Private Networks at Nine Overseas NFL Games
Verizon is deploying temporary private networks across nine international NFL games in eight overseas venues. It also upgraded networks at ten stadiums since last season; customers used 120.7 TB across 15 U.S. Kickoff We
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
SoundHound AI and Ultraviolette Expand Voice AI Across EV Lineup
SoundHound AI and Ultraviolette announced an expansion of agentic voice AI across Ultraviolette’s global electric vehicle lineup.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Geron to Present RYTELO Data at ASH 2026
Geron says new analyses will further characterize RYTELO’s clinical activity and approved dosing regimen in lower-risk MDS.
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
ShelfieTech Closes Acquisition of Majority Interest in Aspect
MNA | Nov 04, 2026, 02:08 PM UTC
M
Alphabet Backs TeraWulf Credit for Anthropic Data Center Project
TeraWulf receives credit backing from Alphabet for its data center project for Anthropic.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Evaxion Reports Preclinical EVX-04 AML Vaccine Data
Evaxion says the data show broad patient coverage, conserved target expression across disease stages and ERV-specific T-cell responses in humanized mice. The company will present the data at the ASH Annual Meeting on Dec
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
AvePoint Appoints Ali Rohani Chief Strategy and Customer Officer
Ali Rohani will lead global strategy and customer experience, including customer success, category and brand strategy.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Dolphin Entertainment to Host Third-Quarter Earnings Call
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
Vivakor Highlights Potential Annual Service Revenue Above $2 Million
Direct Midstream’s conditional agreement to operate 52 New Mexico wells could generate more than $2 million in annual service revenue at targeted operating levels, subject to final fee arrangements. Vivakor’s proposed $4
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Schroders Launches Emerging-Market Bond Fund on Solana
Global asset manager Schroders has launched an emerging-market bond fund on Solana.
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
TeraWulf Gets Google Credit Backing for Anthropic Data Center Project
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
TeraWulf Gets Google Credit Backstop for Anthropic Data-Center Project
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Tangram to Present TGM-148 Preclinical Data at ASH 2026
Tangram says TGM-148 enhances thrombin generation in impaired hemostasis, with no thrombotic safety signals at repeat testing.
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
THORChain’s RUNE Rises 10% as North Korean Hackers Resume Laundering Binance Loot
CRYPTO | Nov 04, 2026, 02:08 PM UTC
L
Cellectar to Present Three Iopofosine Posters at ASH Meeting
Updated Phase 2b analyses show durable responses in heavily pretreated patients. Cellectar will also present a Phase 3 trial-in-progress design; first-patient dosing remains on track for 1Q 2027.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Doba Adds $20 Cash Bonus to Ecommerce Referral Program
Doba announced a $20 cash bonus for its referral program targeting ecommerce marketers.
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Disc Medicine Announces Presentations at ASH Annual Meeting
The company said two oral presentations will feature additional data from its RALLY-MF Phase 2 trial of selcodebart.
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
Chilean Cobalt Agrees to Option La Cobaltera Concessions for $28.3M
Its subsidiary signed a definitive option agreement covering approximately 1,381 hectares of exploitation land and 2,900 hectares of exploration land. Fixed consideration totals $28.3 million in stages, plus a 1.5% royal
MNA | Nov 04, 2026, 02:08 PM UTC
L
AvePoint Appoints Ali Rohani as Chief Strategy and Customer Officer
AvePoint said Ali Rohani, formerly Qualtrics’ Chief Transformation Officer, has joined its executive leadership team.
EQUITY | Nov 04, 2026, 02:08 PM UTC
M
Lyell Reports 91% Overall Response Rate in 3L+ Ronde-Cel Cohort
Lyell reported a 91% overall response rate and 77% complete response rate among 44 Day 84-evaluable patients in its 3L+ trial. In the 2L cohort, rates were 95% and 76% among 37 evaluable patients. Updated data are expect
EQUITY | Nov 04, 2026, 02:08 PM UTC
L
Kura Oncology to Present First FLT3 Combination Data at ASH
Eight ziftomenib abstracts were accepted for presentation at the 2026 ASH Annual Meeting, including preliminary clinical findings from combinations with quizartinib and gilteritinib and longer-term frontline data.
EQUITY | Nov 04, 2026, 02:07 PM UTC
L
Feedonomics Now Available in Amazon’s Shop Direct Merchant Workspace
EQUITY | Nov 04, 2026, 02:07 PM UTC
L
Actinium Pharmaceuticals Announces ASH 2026 Abstract on Actimab-A Combination Results
The abstract reports safety results for targeted alpha therapy combined with CLAG-M in patients with relapsed or refractory AML.
EQUITY | Nov 04, 2026, 02:07 PM UTC
L
Lakefront Biotherapeutics Reports Preliminary Gamgertamig Findings
Preliminary Phase 1b data suggest remission may be retained after B-cell reconstitution without background therapy for autoimmune cytopenias. The company will present the data at ASH on December 13.
EQUITY | Nov 04, 2026, 02:07 PM UTC
L
Royalty Pharma files Form 10-Q for quarter ended Sept. 30
EQUITY | Nov 04, 2026, 02:07 PM UTC